BioDlink International Company Limited (HKG:1875)
Hong Kong
· Delayed Price · Currency is HKD 4.880
+0.300 (6.55%)
Apr 29, 2026, 4:08 PM HKT
HKG:1875 Revenue
In the year 2025, BioDlink International Company had annual revenue of 747.65M CNY, down -31.93%. BioDlink International Company had revenue of 258.51M in the half year ending December 31, 2025, a decrease of -42.88%.
Revenue
747.65M CNY
Revenue Growth
-31.93%
P/S Ratio
4.53
Revenue / Employee
1.22M CNY
Employees
613
Market Cap
3.77B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 747.65M | -350.68M | -31.93% |
| Dec 31, 2024 | 1.10B | 317.70M | 40.70% |
| Dec 31, 2023 | 780.63M | 338.45M | 76.54% |
| Dec 31, 2022 | 442.18M | 365.85M | 479.34% |
| Dec 31, 2021 | 76.33M | 53.83M | 239.36% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Antengene Corporation | 117.22M |
| Viva Biotech Holdings | 1.92B |
| Mirxes Holding Company | 166.32M |
| TYK Medicines | 117.25K |
| Clover Biopharmaceuticals | 3.90M |
| Jiangsu Recbio Technology | 14.16M |
| Medtide | 634.40M |
| Qyuns Therapeutics | 897.99M |